Literature DB >> 8684203

Changing the natural history of HIV disease.

M B Feinberg1.   

Abstract

Our understanding of the pathogenesis of AIDS has advanced considerably since the disease was first reported 15 years ago. We now know that the primary damage inflicted by HIV-1 is mainly brought about by active virus replication. With the advent of sensitive tools for monitoring HIV replication in vivo, an individual's risk of disease progression can be assessed early in the course of the infection and the efficacy of antiviral therapies can now be determined accurately and expeditiously. When used appropriately, potent combinations of antiviral drugs seem to be able to circumvent the inherent tendency of HIV-1 to generate drug-resistant viruses, the main reason for failure of all antiviral therapies, and are significantly more effective than earlier approaches. For the first time, rational approaches to contain and perhaps eliminate HIV-1 infection can be pursued.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684203     DOI: 10.1016/s0140-6736(96)06231-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Antiretroviral therapy for patients with HIV disease.

Authors:  M Barry; F Mulcahy; D J Back
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

2.  Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype.

Authors:  T Kebede; S Britton; T Fehniger; A Vahlne; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 3.  Hepatitis C virus-HIV-coinfected patients and liver transplantation.

Authors:  Ani A Kardashian; Jennifer C Price
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial.

Authors:  A E Muñoz; D Levi; A Podestá; J M Gorín; J González; M A Bartellini; M S Munne; A Cabanne; D Flichman; R Terg
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.

Authors:  Adrian Schmid; Sara Gianella; Viktor von Wyl; Karin J Metzner; Alexandra U Scherrer; Barbara Niederöst; Claudia F Althaus; Philip Rieder; Christina Grube; Beda Joos; Rainer Weber; Marek Fischer; Huldrych F Günthard
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

Review 7.  Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.

Authors:  Peter Chin-Hong; George Beatty; Peter Stock
Journal:  Infect Dis Clin North Am       Date:  2013-03-29       Impact factor: 5.982

8.  Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression.

Authors:  S M Wahl; T Greenwell-Wild; G Peng; H Hale-Donze; T M Doherty; D Mizel; J M Orenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  The narratives of 12 men with AIDS: exploring return to work.

Authors:  Brent Braveman; Christine Helfrich; Gary Kielhofner; Gary Albrecht
Journal:  J Occup Rehabil       Date:  2003-09

Review 10.  Solid organ transplants in HIV-infected patients.

Authors:  Jack Harbell; Norah A Terrault; Peter Stock
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.